Display options
Share it on

JAAD Case Rep. 2018 Nov 14;4(10):1077-1079. doi: 10.1016/j.jdcr.2018.09.022. eCollection 2018 Nov.

Mirtazapine-induced hyperpigmentation with type II histopathologic findings.

JAAD case reports

Kumar Sukhdeo, Garrett H Yoon, Lisa Rothman, Shane A Meehan, Melissa K Levin, Randie H Kim

Affiliations

  1. Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, New York.
  2. NYU School of Medicine, New York, New York.

PMID: 30511003 PMCID: PMC6250903 DOI: 10.1016/j.jdcr.2018.09.022

[No abstract available.]

Keywords: DIH, drug-induced hyperpigmentation; drug-induced hyperpigmentation; hyperpigmentation; iron-drug complexes; melanin-drug complexes; mirtazapine

References

  1. Am J Dermatopathol. 2012 Dec;34(8):e114-8 - PubMed
  2. Am J Dermatopathol. 2014 Jan;36(1):1-48 - PubMed
  3. Semin Arthritis Rheum. 1978 Aug;8(1):33-51 - PubMed
  4. J Am Acad Dermatol. 2007 Nov;57(5):836-9 - PubMed
  5. Am J Clin Dermatol. 2001;2(4):253-62 - PubMed
  6. Prim Care Companion CNS Disord. 2013;15(5):null - PubMed
  7. World J Biol Psychiatry. 2009;10(4 Pt 2):688-9 - PubMed
  8. J Cutan Med Surg. 2005 Dec;9(6):341-5 - PubMed
  9. J Dermatol. 2001 Dec;28(12):742-5 - PubMed
  10. Arch Dermatol. 1993 Apr;129(4):474-6 - PubMed

Publication Types